CN103889412A - 新型苯胺衍生物及其用途 - Google Patents

新型苯胺衍生物及其用途 Download PDF

Info

Publication number
CN103889412A
CN103889412A CN201280049088.5A CN201280049088A CN103889412A CN 103889412 A CN103889412 A CN 103889412A CN 201280049088 A CN201280049088 A CN 201280049088A CN 103889412 A CN103889412 A CN 103889412A
Authority
CN
China
Prior art keywords
dimethylphenyl
amino
cancer
acid
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201280049088.5A
Other languages
English (en)
Chinese (zh)
Inventor
金圣勋
李姬淑
吴莹善
金旲圭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medicinal Bioconvergence Research Center
Original Assignee
Nelmis GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nelmis GmbH filed Critical Nelmis GmbH
Publication of CN103889412A publication Critical patent/CN103889412A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/74—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C07C233/15—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/27—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN201280049088.5A 2011-08-04 2012-08-06 新型苯胺衍生物及其用途 Pending CN103889412A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR10-2011-0077863 2011-08-04
KR20110077863 2011-08-04
KR20120041622A KR20130016041A (ko) 2011-08-04 2012-04-20 신규한 아닐린 유도체 및 이의 용도
KR10-2012-0041622 2012-04-20
PCT/KR2012/006238 WO2013019093A2 (en) 2011-08-04 2012-08-06 Novel aniline derivatives and use thereof

Publications (1)

Publication Number Publication Date
CN103889412A true CN103889412A (zh) 2014-06-25

Family

ID=47895706

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280049088.5A Pending CN103889412A (zh) 2011-08-04 2012-08-06 新型苯胺衍生物及其用途

Country Status (6)

Country Link
US (1) US20140142333A1 (enExample)
EP (1) EP2739279A4 (enExample)
JP (1) JP2014531402A (enExample)
KR (2) KR20130016041A (enExample)
CN (1) CN103889412A (enExample)
WO (1) WO2013019093A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020169054A1 (zh) * 2019-02-22 2020-08-27 浙江海正药业股份有限公司 (E)-α,β-不饱和酰胺化合物的晶型及其制备方法和用途

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130118612A (ko) * 2012-04-20 2013-10-30 (주)네오믹스 신규한 아미노피리딘 유도체 및 이의 용도
WO2014179943A1 (zh) * 2013-05-08 2014-11-13 Yang Yongliang 一种马来酰胺化合物、其制备方法及其用途
KR101762433B1 (ko) * 2013-06-05 2017-07-28 재단법인 의약바이오컨버젼스연구단 신규한 말레인산 유도체 및 이의 제조방법 및 이를 포함하는 항암용 조성물
KR101514320B1 (ko) * 2013-06-14 2015-04-22 재단법인 의약바이오컨버젼스연구단 신규한 암 예방 또는 치료용 약학적 조성물
KR102297505B1 (ko) * 2016-03-07 2021-09-01 재단법인 의약바이오컨버젼스연구단 Aimp2-dx2와 hsp70의 결합을 저해하는 항암제 스크리닝 방법
KR101831435B1 (ko) * 2016-03-10 2018-02-22 재단법인 의약바이오컨버젼스연구단 Aimp2-dx2 단백질에 특이적으로 결합하는 항체
MX2020009416A (es) * 2018-04-13 2021-01-08 Bristol Myers Squibb Co Nuevos reactivos a base de fosforo (v), procesos para su preparacion y su uso en la elaboracion de compuestos de organofosforo (v) estereo-definidos.
US20220204497A1 (en) * 2019-03-29 2022-06-30 Medicinal Bioconvergence Research Center Novel compound having anticancer activity, and method for producing same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100331293A1 (en) * 2009-06-25 2010-12-30 Amgen Inc. Heterocyclic compounds and their uses

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5133610B2 (enExample) * 1973-03-15 1976-09-21
US4125398A (en) * 1975-11-07 1978-11-14 Ciba-Geigy Corporation N-Phenyl-maleic acid amides for regulating the growth and development of plants
CH598213A5 (enExample) * 1976-02-11 1978-05-12 Ciba Geigy Ag
AU614488B2 (en) * 1986-03-31 1991-09-05 Rhone-Poulenc Nederlands B.V. Synergistic plant growth regulator compositions
JPH02183227A (ja) * 1989-01-10 1990-07-17 Seizo Miyata 有機非線形光学材料
JP2683404B2 (ja) * 1989-02-27 1997-11-26 三井東圧化学株式会社 Ｎ―フェニルマレイミド化合物の製造方法
TW321649B (enExample) * 1994-11-12 1997-12-01 Zeneca Ltd
KR100433156B1 (ko) 2001-08-28 2004-05-28 위니아만도 주식회사 열교환기
WO2005037196A2 (en) * 2003-10-06 2005-04-28 Cytovia, Inc. Substituted 2-arylmethylene-n-aryl-n'-aryl-malonamides and analogs as activators of caspases and inducers of apoptosis
CN1934066A (zh) * 2004-03-22 2007-03-21 默克公司 有丝分裂驱动蛋白抑制剂
KR100551009B1 (ko) 2004-05-20 2006-02-13 삼성에스디아이 주식회사 플라즈마 디스플레이 패널과 그의 구동방법
WO2006122546A1 (de) * 2005-05-18 2006-11-23 Forschungsverbund Berlin E.V. Nicht-peptidische inhibitoren der akap-pka-wechselwirkung
KR20100099185A (ko) * 2007-12-21 2010-09-10 제넨테크, 인크. 아자인돌리진 및 이용 방법
MX2011013667A (es) * 2009-06-25 2012-03-06 Amgen Inc Compuestos heterociclicos y sus usos.
WO2011072275A2 (en) * 2009-12-11 2011-06-16 Nono, Inc. Agents and methods for treating ischemic and other diseases
KR20130118612A (ko) * 2012-04-20 2013-10-30 (주)네오믹스 신규한 아미노피리딘 유도체 및 이의 용도

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100331293A1 (en) * 2009-06-25 2010-12-30 Amgen Inc. Heterocyclic compounds and their uses

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
AMITABH JHA ET AL.: "Derivatives of aryl amines containing the cytotoxic butenyl pharmacophore", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》 *
AMITABH JHA: "E,E,E-1-(4-arylamino-4-oxo-2-butenoyl)-3,5-bis(arylidene)-4-piperidones_a topographical study of some novel potent cytotoxins", 《BIOORGANIC & MEDICINAL CHEMISTRY》 *
DAVID J.BEAVER等: "The Preparation and Bacteriostatic Activity of Substituted Ureas", 《JOURNAL OF THE AMERICAN CHEMICAL SOCIETY》 *
KATARZYNA SERAFIN等: "Ethyl malonate amides: A diketo acid offspring fragment for HIV integrase inhibition", 《BIOORGANIC & MEDICINAL CHEMISTRY》 *
M. SORTINO ET AL.: "Antifungal, cytotoxic and SAR studies of a series of N- alkyl, N- aryl and N- alkylphenyl-1,4-pyrrolediones and related compounds", 《BIOORGANIC & MEDICINAL CHEMISTRY》 *
STN: "REGISTRY NUMBER：79199-01-2", 《STN：FILE REGISTRY》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020169054A1 (zh) * 2019-02-22 2020-08-27 浙江海正药业股份有限公司 (E)-α,β-不饱和酰胺化合物的晶型及其制备方法和用途
CN111606828A (zh) * 2019-02-22 2020-09-01 浙江海正药业股份有限公司 (E)-α,β-不饱和酰胺化合物的晶型及其制备方法和用途
CN111606828B (zh) * 2019-02-22 2023-07-28 浙江海正药业股份有限公司 (E)-α,β-不饱和酰胺化合物的晶型及其制备方法和用途

Also Published As

Publication number Publication date
WO2013019093A2 (en) 2013-02-07
EP2739279A4 (en) 2015-08-12
EP2739279A2 (en) 2014-06-11
KR20130016041A (ko) 2013-02-14
US20140142333A1 (en) 2014-05-22
WO2013019093A3 (en) 2013-04-25
JP2014531402A (ja) 2014-11-27
KR20130016134A (ko) 2013-02-14

Similar Documents

Publication Publication Date Title
CN103889412A (zh) 新型苯胺衍生物及其用途
ES2802296T3 (es) Co-cristales de (S)-N-metil-8-(1-((2'-metil-[4,5'-bipirimidin]-6-il)amino)propan-2-il)quinolin-4-carboxamida y derivados deuterados de la misma como inhibidores de DNA-PK
JP6193268B2 (ja) Ｃｄｋ８／ｃｄｋ１９選択的阻害剤、ならびに癌のための抗転移および化学防御の方法におけるそれらの使用
Jiao et al. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents
CN112300145B (zh) 一类靶向stat3双功能磷酸化位点的三芳香环类化合物及其应用
CN105461695A (zh) 嘧啶或三嗪衍生物及其制备方法和用途
ES2787599T3 (es) Inhibidores de leucemia inv(16)
Attia et al. Synthesis and in-vitro anti-proliferative evaluation of some pyrazolo [1, 5-a] pyrimidines as novel larotrectinib analogs
JP6384821B2 (ja) がん細胞阻害薬、がん幹細胞検出用プローブ
ES3037417T3 (en) Purine derivatives as sik-3 inhibitors
JP2014531402A5 (enExample)
JP6327431B2 (ja) がん細胞阻害薬、がん幹細胞検出用プローブ
ES2930081T3 (es) Pirazolopirimidinas sustituidas útiles como inhibidores de quinasas
AU2016368257A1 (en) Five-membered heterocyclic amides wnt pathway inhibitor
D’Alessio et al. Benzodipyrazoles: a new class of potent CDK2 inhibitors
CN106565685A (zh) 微管蛋白抑制剂
Caldwell et al. Discovery of acyl ureas as highly selective small molecule CSF1R kinase inhibitors
CN104379565A (zh) 新型氨基吡啶衍生物的癌预防或治疗用途
JP6424155B2 (ja) 白血病を治療するための化合物および方法
US9399644B2 (en) [1,3] dioxolo [4,5-G] quinoline-6(5H)thione derivatives as inhibitors of the late SV40 factor (LSF) for use in treating cancer
CN106045973A (zh) 4‑酰胺基苯并咪唑吖啶类化合物及其制备方法和用途
CN109096194B (zh) 一种双胍衍生物、药物组合物、制备方法和用途
KR102682516B1 (ko) 퀴놀린 구조를 갖는 pan-kit 키나제 억제제 및 이의 용도
CN107056754B (zh) 内嵌脲类结构的wnt通路抑制剂
CN103819467A (zh) 喹唑啉衍生物的制备方法及其用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: MEDICINAL BIOCONVERGENCE RESEARCH CENTER

Free format text: FORMER OWNER: NIERMICE CO., LTD.

Effective date: 20150521

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20150521

Address after: Gyeonggi Do, South Korea

Applicant after: MEDICINAL BIOCONVERGENCE RESEARCH CENTER

Address before: Gyeonggi Do, South Korea

Applicant before: MEDICINAL BIOCONVERGENCE RESEARCH CENTER

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140625